Related Experiment Video
Updated: Jun 23, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Structural MRI and mild behavioral impairment as complementary predictors of conversion from amnestic MCI to
Alexander Tomyshev1, Nikita Cherkasov2, Yana Panikratova1
1Laboratory of Neuroimaging and Multimodal Analysis, Mental Health Research Center, Moscow, Russian Federation.
Abstract:
Mild Behavioral Impairment (MBI) and amnestic Mild Cognitive Impairment (aMCI) are complementary early markers of Alzheimer's disease (AD), yet their combined neuroanatomical correlates and predictive value for conversion remain underexplored. In this study of 72 community-dwelling older adults (49 aMCI, 23 healthy controls), we retrospectively classified aMCI participants into non-converters (aMCI-NC, n = 31) and converters (aMCI-C, n = 18) based on longitudinal follow-up. Baseline structural MRI revealed that aMCI-C patients exhibited bilateral atrophy in the hippocampus, amygdala, and nucleus accumbens, alongside cortical thinning in temporal-limbic and parietal regions compared to both aMCI-NC and controls. Notably, in the non-converter group, MBI-Checklist scores correlated negatively with temporal-parietal cortical thickness, while Montreal Cognitive Assessment scores correlated positively with subcortical volumes. Cox proportional-hazards regression with supervised principal component analysis revealed that while MBI symptoms alone did not independently predict conversion, they demonstrated significant conditional predictive value when combined with structural MRI markers. Model robustness was confirmed via rigorous internal validation using nested leave-one-out cross-validation with bootstrap aggregation. Furthermore, time-varying analysis indicated that the protective effect of larger medial temporal-limbic subcortical volumes was strong initially but attenuated over follow-up, consistent with a depletable brain reserve. Given the limited conversion events, which constrained statistical power for smaller independent effects and restricted model complexity, replication in larger prospective cohorts is warranted. Despite this limitation, our results underscore the conditional utility of integrating MBI assessment with structural MRI to enhance early detection and risk stratification in memory clinic settings.
Insights
Mild Behavioral Impairment (MBI) and amnestic Mild Cognitive Impairment (aMCI) predict Alzheimer's disease (AD) conversion when combined with MRI. MBI symptoms alone did not predict conversion, but structural MRI markers showed conditional predictive value.
Area of Science:
- Neuroscience
- Gerontology
- Radiology
Background:
- Mild Behavioral Impairment (MBI) and amnestic Mild Cognitive Impairment (aMCI) are early Alzheimer's disease (AD) indicators.
- Their combined neuroanatomical correlates and predictive power for AD conversion require further investigation.
Purpose of the Study:
- To explore the combined neuroanatomical correlates of MBI and aMCI.
- To assess their predictive value for conversion to AD.
Main Methods:
- Retrospective classification of 72 participants (49 aMCI, 23 controls) into converters and non-converters.
- Baseline structural MRI analysis to identify atrophy and cortical thinning.
- Cox regression and supervised principal component analysis for predictive modeling.
Main Results:
- aMCI converters showed hippocampal, amygdala, and nucleus accumbens atrophy, plus temporal-parietal thinning.
- MBI scores correlated with reduced cortical thickness in non-converters.
- MBI symptoms combined with MRI markers showed conditional predictive value for conversion.
Conclusions:
- Integrating MBI assessment with structural MRI enhances early AD detection and risk stratification.
- Brain reserve, indicated by subcortical volumes, may attenuate over time.
- Replication in larger prospective cohorts is recommended due to limited conversion events.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction

